Guardant Health Inc
NASDAQ:GH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
S
|
Shinsegae Engineering & Construction Inc
KRX:034300
|
KR |
|
Industrie Chimiche Forestali SpA
MIL:ICF
|
IT |
|
S
|
Swiss Properties Invest A/S
CSE:SWISS
|
DK |
|
I
|
Ingram Micro Holding Corp
NYSE:INGM
|
US |
|
D
|
DSM-Firmenich AG
OTC:DSMFF
|
CH |
|
Y
|
Yuexiu Real Estate Investment Trust
HKEX:405
|
HK |
|
R
|
Raytheon Technologies Corp
F:5UR
|
US |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
IN |
|
Safety Insurance Group Inc
NASDAQ:SAFT
|
US |
|
Optiva Inc
TSX:OPT
|
CA |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
Wall St Price Targets
GH Price Targets Summary
Guardant Health Inc
According to Wall Street analysts, the average 1-year price target for GH is 193.817 USD with a low forecast of 93.334 USD and a high forecast of 236.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GH's stock price target?
Price Target
193.817
USD
According to Wall Street analysts, the average 1-year price target for GH is 193.817 USD with a low forecast of 93.334 USD and a high forecast of 236.25 USD.
What is the Revenue forecast for Guardant Health Inc?
Projected CAGR
23%
Over the last 8 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is 23%.
What is the Gross Profit forecast for Guardant Health Inc?
Projected CAGR
24%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 56%. The projected CAGR for the next 8 years is 24%.
